Blocking PD-L2 or depletion of MGL2+ cells selectively activated CD8+ T cells and suppressed metastasis, suggesting that DCs use this pathway to inhibit CD8+ T-cell-mediated tumor immunity [96]. This evidence concerns the gene CD8A and neoplasm.